Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin

Author:

Cai Sidong,Wang Panxia,Xie Tingting,Li Zhenzhen,Li Jingyan,Lan Rui,Ding Yanqing,Lu Jing,Ye Jiantao,Wang Junjian,Li Zhuoming,Liu Peiqing

Funder

National Natural Science Foundation of China

Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program

National Major Special Projects for the Creation and Manufacture of New Drugs

Special Program for Applied Science and Technology of Guangdong Province

National Engineering and Technology Research Center for New drug Druggability Evaluation

Guangdong Basic and Applied Basic Research Foundation

Guangzhou Science and Technology Program Project

Yang Fan Project of Guangdong Province

Guangdong Provincial Key Laboratory of Construction Foundation

Publisher

Elsevier BV

Subject

Pharmacology

Reference64 articles.

1. Epidemiology and risk profile of heart failure;Bui;Nat. Rev. Cardiol.,2011

2. Heart disease and stroke statistics–2016 update: a report from the American Heart Association;Mozaffarian;Circulation,2016

3. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure;Stewart;Eur. J. Heart Fail.,2001

4. Physiological and pathological cardiac hypertrophy;Shimizu;J. Mol. Cell. Cardiol.,2016

5. Molecular basis of physiological heart growth: fundamental concepts and new players;Maillet;Nat. Rev. Mol. Cell Biol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3